Peptides
TAT-327 - 1mg
$265.00
Check your price
- Cat.Number : AS-65676
- Manufacturer Ref. :
-
Availability :
In stock
TAT-327 is the conjugation of Eps8-derived peptide 327 (Cat# AS-65675) to the TAT sequence resulted in potent antitumor effect by inhibiting the Eps8/EGFR interaction and selective insertion into cancer cell membranes.
Specifications
| Chemistry | |
| Sequence one letter code |
|
|---|---|
| Sequence three letter code |
|
| Molecular Formula |
|
| Molecular Mass/ Weight |
|
| Modification | |
| Conjugation |
|
| Quantity & Purity | |
| Purity |
|
| Storage & stability | |
| Form |
|
| Activity | |
| Biomarker Target | |
| Research Area | |
| Sub-category Research Area | |
| Usage |
|
| Source | |
| Source / Species |
|
You may also be interested in the following product(s)
EGF Receptor Substrate 2 [DADE-pY-LIPQQG], 5-FAM labeled - 5 mg
Cat.Number :
AS-29971-5
$1,533.00
Excl. Tax
EGF Receptor Substrate 2 [DADE-pY-LIPQQG], Biotinylated - 1 mg
Cat.Number :
AS-29972-1
$260.00
Excl. Tax